Abstract10.1016/j.jtho.2023.09.614P2.09-41 Phase I/II Study Exploring Safety and Efficacy of Apl-101 Plus Frontline Osimertinib in EGFR-mutated Metastatic Non-small Cell Lung CancerOct 31, 2023Journal of Thoracic OncologyB Patel + 13 more +13RelevantCiteListenSave